IGF2BP3 and nasopharyngeal carcinoma: Notably, ectopic expression of IGF2BP3 potently increased NANOG, OCT4, and CD44 levels in NPC tumors, while silencing IGF2BP3 potently impaired stemness marker levels in tumors (Supplementary Fig. 3B).